Tamashiro, Tamaki
Tanaka, Koji
Itagaki, Kanako
Nakayama, Makiko
Maruko, Ichiro
Wakugawa, Sorako
Terao, Nobuhiro
Onoe, Hajime
Wakatsuki, Yu
Ogasawara, Masashi
Sugano, Yukinori
Yamamoto, Akiko
Kataoka, Keiko
Izumi, Takahiko
Kawai, Moeko
Mori, Ryusaburo
Sekiryu, Tetsuju
Okada, Annabelle A.
Iida, Tomohiro
Koizumi, Hideki http://orcid.org/0000-0002-9610-4386
,
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP21K09746)
Article History
Received: 29 June 2021
Revised: 28 November 2021
Accepted: 6 December 2021
First Online: 16 January 2022
Declarations
:
: The study protocol was approved by the institutional review board of each university and was conducted in accordance with the guidelines of the Declaration of Helsinki.
: Written informed consent was obtained from all the patients included in this study.
: Dr. Tamashiro reported personal fees from Alcon, Novartis, and Senju outside the submitted work. Dr. Tanaka reported personal fees from Alcon, Bayer, Novartis, Santen, and Senju outside the submitted work. Dr. Itagaki reported personal fees from Bayer and Novartis outside the submitted work. Dr. Nakayama has nothing to disclose. Dr. Maruko reported grants from JSPS KAKENHI (Grant Number JP20K09781); personal fees from Alcon, Bayer, Canon, Nidek, Novartis, Santen, Senju, and Topcon outside the submitted work. Dr. Wakugawa reported personal fees from Senju and Novartis outside the submitted work. Dr. Terao reported personal fees from Bayer, Nidek, Novartis, Senju, Santen, and Topcon outside the submitted work. Dr. Onoe reported personal fees from AMO and Novartis outside the submitted work. Dr. Wakatsuiki reported personal fees from Bayer outside the submitted work. Dr. Ogasawara has nothing to disclose. Dr. Sugano has nothing to disclose. Dr. Yamamoto reported personal fees from Alcon, Bayer, Novartis, Otsuka, and Santen outside the submitted work. Dr. Kataoka reported personal fees from Bayer, Novartis, Santen, and Senju outside the submitted work. Dr. Izumi reported personal fees from Senju and Topcon outside the submitted work. Dr. Kawai has nothing to disclose. Dr. Mori reported personal fees from Novartis, Bayer, Senju, Santen, Bausch & Lomb, JFC, Nikon, and Acula outside the submitted work. Dr. Sekiryu reported personal fees from Novartis, Bayer, Senju, Santen, Kowa, Allergan, and Chugai outside the submitted work. Dr. Okada reported consulting fees from Astellas, Bayer, Biocon Biologics, Daiichi Sankyo, HOYA, Kowa, and Novartis; personal support from Abbvie, Alcon, Bayer, Mitsubishi Tanabe, Novartis, Pfizer, Santen, and Senju outside the submitted work. Dr. Iida reported consulting fees from Bayer and Chugai; personal fees from AMO, Alcon, Bayer, Canon, HOYA, JFC, Kowa, Nikon, Nidek, Novartis, Otsuka, Pfizer, Santen, Senju, and Topcon outside the submitted work. Dr. Koizumi reported grants from JSPS KAKENHI (Grant Number JP21K09746); personal fees from Novartis, Alcon, Bayer, Canon, Senju, Santen, Kowa, HOYA, AMO, Otsuka, Pfizer, Allergan, Bausch & Lomb, JFC, Nidek, Topcon, Abbvie, TOMEY, Sumitomo Dainippon Pharma, Chugai, and SANOFI outside the submitted work.